Bioavailability and pharmacokinetic study of slow release preparations of sodium valproate (Depakene-R Tablets,NIK-240)were investigated by a cross-over design in six healthy volunteers.When bioavailability parameters were compared between two preparations after a single dose of 600mg of each drug was administered orally,there was difference in maximum serum concentration(C.),but no difference was found in areas under the serum concentration-time curve(AUC),peak time(Tmax),mean residence time(MRT)and variance of residence time(VRT).
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